William A. Hagstrom - May 14, 2021 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Director
Signature
/s/ Peter Maag as attorney-in-fact for William A. Hagstrom
Stock symbol
CDNA
Transactions as of
May 14, 2021
Transactions value $
-$668,884
Form type
4
Date filed
5/17/2021, 04:16 PM
Next filing
Jun 11, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $27.8K +4.75K +25.55% $5.85 23.3K May 14, 2021 Direct
transaction CDNA Common Stock Options Exercise $26.4K +5.26K +22.53% $5.02 28.6K May 14, 2021 Direct
transaction CDNA Common Stock Sale -$574K -8.59K -30.05% $66.82 20K May 14, 2021 Direct F1
transaction CDNA Common Stock Sale -$95K -1.41K -7.06% $67.29 18.6K May 14, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Stock Option (right to buy) Options Exercise -$27.8K -4.75K -90.29% $5.85 510 May 14, 2021 Common Stock 4.75K $5.85 Direct F3
transaction CDNA Stock Option (right to buy) Options Exercise -$26.4K -5.26K -100% $5.02 0 May 14, 2021 Common Stock 5.26K $5.02 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.14 to $67.14, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.28 to $67.395, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 1/12th of the shares subject to the option vested on July 17, 2015 and 1/12th of the shares subject to the option vested monthly thereafter.
F4 1/12th of the shares subject to the option vested on July 16, 2016 and 1/12th of the shares subject to the option vested monthly thereafter.